These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2269819)

  • 1. [Countermeasure for adverse effects of therapeutic agents for systemic lupus erythematosus].
    Torikai K
    Nihon Naika Gakkai Zasshi; 1990 Oct; 79(10):1416-20. PubMed ID: 2269819
    [No Abstract]   [Full Text] [Related]  

  • 2. [Invasive disseminated aspergillosis in combined immunosuppressive therapy in systemic lupus erythematosus].
    Teuber G; Schwarting A; Mildenberger P; Schmidt-Brücken G; Moll R; Bornemann A; Wandel E; Wanitschke R; Meyer zum Büschenfelde KH
    Med Klin (Munich); 1996 Dec; 91(12):798-801. PubMed ID: 9082168
    [No Abstract]   [Full Text] [Related]  

  • 3. [Case of systemic erythematodes on long-term care with repeated development of severe cytomegalovirus infection].
    Masago R; Fukuma H
    Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1555-6. PubMed ID: 9780684
    [No Abstract]   [Full Text] [Related]  

  • 4. Infections in systemic lupus erythematosus.
    Navarra SV; Leynes MS
    Lupus; 2010 Oct; 19(12):1419-24. PubMed ID: 20947551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
    Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in childhood systemic lupus erythematosus.
    Wedgwood RJ
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):295-8. PubMed ID: 263906
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary malignant lymphoma of the brain following immunosuppressive therapy of systemic lupus erythematosus].
    Matsuura T; Nakabayashi H; Yanagisawa T; Yamazaki K; Watanabe R; Kameda H; Sakata A
    Nihon Naika Gakkai Zasshi; 1987 May; 76(5):730-5. PubMed ID: 3509103
    [No Abstract]   [Full Text] [Related]  

  • 8. The management of systemic lupus erythematosus: Facts and controversies.
    Elbirt D; Sthoeger D; Asher I; Sthoeger ZM
    Clin Dermatol; 2010; 28(3):330-6. PubMed ID: 20541688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunistic infections mimicking gastrointestinal vasculitis in systemic lupus erythematosus.
    Diep JT; Kerr LD; Sarebahi S; Tismenetsky M
    J Clin Rheumatol; 2007 Aug; 13(4):213-6. PubMed ID: 17762457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmonella infection in systemic lupus erythematosus.
    Boey ML; Feng PH
    Singapore Med J; 1982 Jun; 23(3):147-51. PubMed ID: 7146919
    [No Abstract]   [Full Text] [Related]  

  • 11. [Herpes zoster occurring consecutively in hospitalized children with systemic lupus erythematosus].
    Ueda K; Arihiro H; Nunoue T; Hirano Y; Goya N
    Nihon Rinsho; 1974 Mar; 32(3):632-5. PubMed ID: 4858995
    [No Abstract]   [Full Text] [Related]  

  • 12. Urticarial vasculitis in systemic lupus erythematosus: fair response to prednisolone/dapsone and persistent hypocomplementemia.
    Nishijima C; Hatta N; Inaoki M; Sakai H; Takehara K
    Eur J Dermatol; 1999; 9(1):54-6. PubMed ID: 9920991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aseptic bone necrosis in systemic lupus erythematosus].
    Borisov IA; Bochman NL; Tavonius KE; Tareeva IE
    Sov Med; 1973 Nov; 36(11):103-7. PubMed ID: 4787403
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lupus erythematosus, modern aspects (author's transl)].
    Canavese JC
    Schweiz Rundsch Med Prax; 1977 May; 66(19):565-72. PubMed ID: 69300
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis.
    Eguchi K
    Intern Med; 2002 Feb; 41(2):77-8. PubMed ID: 11868611
    [No Abstract]   [Full Text] [Related]  

  • 16. An open study of B lymphocyte depletion in systemic lupus erythematosus.
    Leandro MJ; Edwards JC; Cambridge G; Ehrenstein MR; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2673-7. PubMed ID: 12384926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinogenesis caused by immunosuppression. Tumor development in successful treatment of LE glomerulonephritis of (NBZ x NZW) mice with cytostatic agents, prednisolone and a combination of both].
    Mitrou PS; Fischer M; Mitrou G
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():862-4. PubMed ID: 612065
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical aspects and diagnosis of systemic lupus erythematosus].
    Hiepe F; Burmester GR
    Dtsch Med Wochenschr; 1996 Sep; 121(36):1095-100. PubMed ID: 8846755
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasopressin cell antibodies and central diabetes insipidus in a patient with systemic lupus erythematosus and dermatomyositis.
    Kajiyama H; Terai C; De Bellis A; Bizzarro A; Bellastella A; Ohta S; Okamoto H; Uesato M; Hara M; Kamatani N
    J Rheumatol; 2004 Jun; 31(6):1218-21. PubMed ID: 15170939
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic principles in systemic lupus erythematosis with phospholipid syndrome].
    Reshetniak TM; Alekberova ZS; Nasonov EL; Nasonova VA
    Ter Arkh; 1998; 70(5):83-7. PubMed ID: 9644754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.